Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Carbohydrate Research
|
May 18, 2011
Preparation of 1-C-glycosyl aldehydes by reductive hydrolysis
Szabolcs Sipos, István Jablonkai
Carbohydrate Research
|
November 16, 2011
Preparation of 2-amino-2-C-glycosyl-acetonitriles from C-glycosyl aldehydes by Strecker reaction
Szabolcs Sipos, István Jablonkai, Orsolya Egyed, et al.
Chemmedchem
|
February 3, 2025
Structure-Atropisomer Stability Relationship in Selective MCL-1 Inhibitors
Szabolcs Sipos, Barbara Balazs, Tamas Gati, et al.
ACS Omega
|
September 9, 2021
The Effect of Core Replacement on S64315, a Selective MCL-1 Inhibitor, and Its Analogues
Szabolcs Sipos, Balázs Bálint, Zoltán B Szabó, et al.
Journal of Medicinal Chemistry
|
November 4, 2020
Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor
Zoltan Szlavik, Marton Csekei, Attila Paczal, et al.
Nature
|
October 28, 2016
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
András Kotschy, Zoltán Szlavik, James Murray, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Carbohydrate Research
|
May 18, 2011
Preparation of 1-C-glycosyl aldehydes by reductive hydrolysis
Szabolcs Sipos, István Jablonkai
Carbohydrate Research
|
November 16, 2011
Preparation of 2-amino-2-C-glycosyl-acetonitriles from C-glycosyl aldehydes by Strecker reaction
Szabolcs Sipos, István Jablonkai, Orsolya Egyed, et al.
Chemmedchem
|
February 3, 2025
Structure-Atropisomer Stability Relationship in Selective MCL-1 Inhibitors
Szabolcs Sipos, Barbara Balazs, Tamas Gati, et al.
ACS Omega
|
September 9, 2021
The Effect of Core Replacement on S64315, a Selective MCL-1 Inhibitor, and Its Analogues
Szabolcs Sipos, Balázs Bálint, Zoltán B Szabó, et al.
Journal of Medicinal Chemistry
|
November 4, 2020
Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor
Zoltan Szlavik, Marton Csekei, Attila Paczal, et al.
Nature
|
October 28, 2016
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
András Kotschy, Zoltán Szlavik, James Murray, et al.
Page
of 1